| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5686396 | The Journal of Urology | 2017 | 20 Pages |
Abstract
The risk of bleeding complications due to antiplatelet therapy use at partial nephrectomy may be due to clopidogrel. The need to continue perioperative aspirin alone does not appear to be a contraindication to the safe performance of partial nephrectomy.
Keywords
R.E.N.A.L.DAPTASA®EBLACC/AHAAspirinDESdrug eluting stentAmerican Society of Anesthesiologists®estimated blood lossminimally invasive surgeryHemorrhagedual antiplatelet therapyRenal cellAntiplateletPartial nephrectomyNephrectomyNephrometry scoremisCarcinomaAmerican College of Cardiology/American Heart Associationclopidogrel
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Timothy Ito, Ithaar H. Derweesh, Serge Ginzburg, Philip H. Abbosh, Omer A. Raheem, Hossein Mirheydar, Zachary Hamilton, David Y.T. Chen, Marc C. Smaldone, Richard E. Greenberg, Rosalia Viterbo, Alexander Kutikov, Robert G. Uzzo,